Cendakimab
Product Specifications
CAS Number
2151032-62-9
Target
Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.96
Bioactivity
Cendakimab (RPC4046) is a humanized monoclonal antibody targeting IL-13. It selectively targets the IL-13 receptor (IL13R-α1 and IL13R-α2), used in research on atopic dermatitis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog